Gregory Light, Ph.D. Education/Training Institution and Location Degree, if applicable Year(s) Field of Study Nazareth College, Rochester NY BA 1993 Psychology University of California San Diego Internship 2000 Clinical Neuropsychology University of California San Diego Ph.D. 2001 Clinical Neuropsychology University of California San Diego PostDoc 2003 Biological Psychiatry and Neuroscience A. Positions and Employment 1993-1995 Laboratory Manager, University of Rochester, Rochester, NY 1995-2000 Graduate Research Assistant, University of California, San Diego 1997-1998 Adjunct Faculty, San Diego State University, San Diego, CA 1998-Present Neuropsychological Consultant, San Diego Chargers 2000-2001 Intern in Clinical Neuropsychology, University of California, San Diego 2001-2003 Post Grad Research Scientist IV, NIMH Post Doctoral Fellowship Program in Biological Psychiatry and Neuroscience, University of California, San Diego 2003-Present Assistant Professor, Department of Psychiatry, University of California, San Diego 2003-Present Assistant Professor, Faculty in Experimental Psychopathology, SDSU/UCSD Jt. Doctoral Program in Clinical Psychology 2003-Present Co-director of Schizophrenia and Cognitive Disorders Clinics, Department of Psychiatry, University of California, San Diego School of Medicine 2004-Present UCSD Site coordinator, Consortium on the Genetics of Schizophrenia Honors and Awards 2001 Society for Neuroscience Fellowship Award 2002 Society of Biological Psychiatry Fellowship Award 2003 Young Investigator Award, International Congress on Schizophrenia Research 2003 Young Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD) 2004 Young Investigator Award, Winter Workshop on Schizophrenia 2004 Bowman Family Foundation Investigator (2003), National Alliance for Research on Schizophrenia and Depression Memberships Program Committee, Society of Biological Psychiatry Society of Biological Psychiatry, member International Congress on Schizophrenia Research Society for Psychophysiological Research Behavior and Brain Sciences Associate Society for Neuroscience B. Selected peer-reviewed publications (in chronological order). Light GA, Braff DL (in press): Mismatch negativity deficits are associated with poor functioning in schizophrenia, Arch Gen Psychiatry. Light GA, Braff DL (in press): Mismatch negativity deficits and their relationship to functional impairments are stable in chronic schizophrenia patients. Am J Psychiatry. Braff DL, Light GA (in press): Preattentional and attention-dependent cognitive deficits as targets for treating schizophrenia, Psychopharmacology. Light GA (in press): Probing cortical-cortical interactions that underlie the multiple sensory, cognitive, and “real-world” functional deficits in schizophrenia, Behavioral and Brain Sciences. Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR (in press): Female schizophrenia patients have prepulse inhibition deficits. Biological Psychiatry. Meincke U, Light GA, Geyer MA, Braff DL (in press): On the waveform of the acoustic startle blink in the paradigm of prepulse inhibition - methodological and physiological aspects. Neuropsychobiology. Meincke U, Light GA, Geyer MA, Braff DL, Gouzoulis-Mayfrank E (in press): Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia, Psychiatry Research. Swerdlow NR, Stephany NL, Talledo J, Light GA, Braff DL, Bayens D, Auerbach PP (in press): Prepulse inhibition of perceived stimulus intensity: Paradigm assessment. Biological Psychology. Light GA, Braff DL (2003): Sensory gating deficits in schizophrenia: can we parse the effects of medication, nicotine use, and changes in clinical status? Clinical Neuroscience Research 3:47-54. Green MF, Nuechterlein KH, Breitmeyer B, Mintz J, Braff DL, Light GA, & Salveson D (2003): Abnormal gamma range activity in schizophrenia: Evidence from visual masking. Biol Psychiatry 53:1113-1119. Cadenhead KS, Light GA, Geyer MA, McDowell JE, & Braff DL (2002): Neurobiological measures in schizotypal personality disorder: Can we define a phenotype? Am J Psychiatry 159:869-71. Light GA, & Braff DL (2001): Measuring P50 suppression and prepulse inhibition in a single recording session. Am J Psychiatry 158:2066-2068. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, & Swerdlow NR (2001): Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res, 49(1-2), 171-178. Light GA, & Braff, DL (2000): Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? Biol Psychiatry, 47(5), 463-467. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL (2000): Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry 157:767-71. Cadenhead KS, Light GA, Geyer MA, Braff DL (2000): Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 157:55-9. Perry W, Light GA, Davis H, & Braff DL (2000): Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophr Res, 46(2-3), 167-174. Light GA, Malaspina D, Geyer MA, Luber BM, Coleman EA, Sackeim HA, Braff DL (1999): Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry 46:990-996. Light GA, Braff DL (1999): Human and animal studies of schizophrenia-related gating deficits. Current Psychiatry Reports 1:31-41. Silverstein S, Light G, Palumbo D (1998): The Sustained Attention Test: A measure of attentional disturbance. Computers in Human Behavior 14:463-475. Light GA, Braff DL (1998): The "incredible shrinking" P50 event-related potential. Biol Psychiatry 43:918-20. Braff DL, Light GA (1998): Selection of digital filtering parameters and P50 amplitude-Response. Biol Psychiatry 43:922.